Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...
After over a decade of leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini is stepping down as Dir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results